Sagentia Innovation vs Delve: full comparison for 2026
Quick verdict
Sagentia Innovation (4.1/5) edges ahead of Delve (4.0/5) overall. Sagentia Innovation is the better choice for surgical robotics and combination products. Delve is the stronger option for user research and industrial design for medtech. The right choice depends on your project size, budget, and required tech stack.
Sagentia Innovation vs Delve: head-to-head summary
| Criterion | Sagentia Innovation | Delve |
|---|---|---|
| Founded | 1986 | 2021 |
| HQ | Harston, Cambridge, UK | Madison, WI, USA |
| Team size | 650+ (Science Group) | 200–500 |
| Rating | 4.1 / 5 | 4.0 / 5 |
| Primary differentiator | Medical development backed by a listed science group that also runs a regulatory consultancy | Design research and industrial design depth from two long-established US studios |
| Pricing model | Time and materials, fixed project | Time and materials, phased fixed project |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, Robotics, Mechanical simulation | SolidWorks, Usability engineering, Rapid prototyping |
| Industries served | Surgical & robotics, Drug delivery, Diagnostics & lab devices | Wearables & remote monitoring, Surgical & therapeutic devices, Consumer products, Industrial |
Sagentia Innovation vs Delve: overview
Sagentia Innovation
Sagentia Innovation is owned by Science Group plc, which is listed on the London Stock Exchange's AIM market. Its roots go back to 1986; the current business was formed in 2021 from Sagentia, OTM Consulting and Oakland Innovation. It is based at Harston Mill near Cambridge, with R&D facilities in Cambridge and Epsom, and its medical work covers devices, combination products and surgical robotics. Science Group employs more than 650 people across all its businesses.
Delve
Delve is a product design and innovation firm headquartered in Madison, Wisconsin, with studios in Boston, Philadelphia and San Francisco. Trinity Hunt Partners bought it in 2021 and merged it with Philadelphia's Bresslergroup (founded 1970), and the combined business now operates under the Delve name and later acquired digital design firm altr. Its team is estimated at 200 to 500 people. Delve says it designed and engineered the Dexcom G6 continuous glucose monitor (per company website; independently unverifiable), and medical devices are a large share of its work alongside consumer and industrial products.
Services and capabilities: Sagentia Innovation vs Delve
| Capability | Sagentia Innovation | Delve |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✗ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✗ | ✓ |
| Mechanical engineering | ✓ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✓ | ✗ |
| Manufacturing & scale-up | ✗ | ✗ |
Tech stack comparison: Sagentia Innovation vs Delve
| Framework / platform | Sagentia Innovation | Delve |
|---|---|---|
| Embedded C/C++ | ✓ | ✓ |
| Embedded Linux | N/A | N/A |
| RTOS | N/A | N/A |
| BLE | N/A | N/A |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | N/A | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | ✓ | N/A |
| Qt | N/A | N/A |
Pricing comparison: Sagentia Innovation vs Delve
| Criterion | Sagentia Innovation | Delve |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Consulting, Fixed project, Time & materials | Consulting, Fixed project, Time & materials |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Sagentia Innovation vs Delve
| Dimension | Sagentia Innovation | Delve |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Surgical & robotics, Drug delivery, Diagnostics & lab devices | Wearables & remote monitoring, Surgical & therapeutic devices, Consumer products |
| Best use cases | Surgical robot subsystem development, Drug-device combination product engineering | Industrial design and user research for a wearable, Human factors work on a home-use device |
| Typical project type | Consulting | Consulting |
Sagentia Innovation vs Delve: pros and cons
| Sagentia Innovation | |
|---|---|
| + | Active surgical robotics software and hardware hiring shows current work in that area |
| + | Sister business TSG Consulting has a medical device regulatory team |
| + | Large owned R&D facilities in Cambridge and Epsom |
| + | About 30 years of medical device projects |
| - | Part of a listed group, so commercial priorities answer to public shareholders |
| - | Recent 2021 merger means the brand and teams are relatively new |
| - | Science Group headcount covers many businesses, so the medtech team size is unclear |
| Delve | |
|---|---|
| + | Strong user research and industrial design, important for patient-worn devices |
| + | Multiple US studios |
| + | Public wearable CGM experience |
| + | Bresslergroup brings a long patent and design-award record |
| - | Private-equity owned since 2021 and built through mergers |
| - | Medical is a large share, but consumer and industrial work compete for attention |
| - | ISO 13485 certification was not confirmed in our research |
Who should choose Sagentia Innovation?
A typical fit: surgical robot subsystem development.
Medical development backed by a listed science group that also runs a regulatory consultancy. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & robotics, Drug delivery, Diagnostics & lab devices.
Who should choose Delve?
A typical fit: industrial design and user research for a wearable.
Design research and industrial design depth from two long-established US studios. Minimum engagement is not publicly disclosed. Works best with clients in Wearables & remote monitoring, Surgical & therapeutic devices, Consumer products, Industrial.
Decision matrix: Sagentia Innovation vs Delve
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Sagentia Innovation |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Sagentia Innovation (Not disclosed) vs Delve (Not disclosed) |
| You need specialist depth in a specific vertical | Delve |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Sagentia Innovation vs Delve
| Use case | Sagentia Innovation fit | Delve fit | Winner |
|---|---|---|---|
| Surgical robot subsystem development | Strong | Limited | Sagentia Innovation |
| Drug-device combination product engineering | Strong | Limited | Sagentia Innovation |
| Industrial design and user research for a wearable | Limited | Strong | Delve |
| Human factors work on a home-use device | Limited | Strong | Delve |
Verdict: Sagentia Innovation vs Delve
Sagentia Innovation (4.1/5) is the stronger overall choice for most Medical Device Development projects. Medical development backed by a listed science group that also runs a regulatory consultancy.
Delve (4.0/5) is worth a look if you need human factors work on a home-use device. If your situation matches that, Delve is a competitive option.
Related comparisons
Sagentia Innovation vs Delve FAQ
Is Sagentia Innovation better than Delve?
Sagentia Innovation (4.1/5) scores higher overall, but "better" depends on your use case. Sagentia Innovation's strongest advantage: active surgical robotics software and hardware hiring shows current work in that area. Delve's strongest advantage: strong user research and industrial design, important for patient-worn devices.
How do Sagentia Innovation and Delve differ in pricing?
Sagentia Innovation uses time and materials, fixed project pricing. Delve uses time and materials, phased fixed project pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Sagentia Innovation or Delve?
Delve is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Sagentia Innovation and Delve?
Sagentia Innovation's primary differentiator is: medical development backed by a listed science group that also runs a regulatory consultancy. Delve's primary differentiator is: design research and industrial design depth from two long-established US studios. They also differ in team size (650+ (Science Group) vs 200–500), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Surgical & robotics, Drug delivery vs Wearables & remote monitoring, Surgical & therapeutic devices).
Verify all details directly with each company before making a decision.